SAT01.1

13:15

An Effective Long-Term Strategy for the Treatment of Plaque Psoriasis

C. Griffiths (Manchester; United Kingdom)

SAT01.2

13:35

A more Selective Approach to Psoriasis Treatment

J. Prinz (Munich, Germany)

SAT01.3

13:55

Why do Patients with Psoriasis Receive Biologics and how do they Respond?

R. Gniadecki (Copenhagen, Denmark)

L. Puig Sanz (Barcelona, Spain)

K. Kragballe (Aarhus, Denmark)

SAT01.4

14:35

Discussion

All

SAT02.1

13.15

Welcome and Introduction

T. Ruzicka (Munich, Germany)

SAT02.2

13.20

Different “Faces” of Rosacea

A. Layton (Harrogate, United Kingdom)

SAT02.3

13.40

Rosacea: an Inflammatory Disease

D. Thiboutot (Pennsylvania, USA)

SAT02.4

14.00

Management of Rosacea

M. Schaller (Tubingen, Germany)

SAT02.5

14.15

The New Approach: Anti-inflammatory Dose Doxycycline

T. Ruzicka (Munich, Germany)

SAT02.6

14.35

Questions & Answers

SAT03.1

13:15

Welcome

U. Mrowietz (Kiel, Germany)

SAT03.2

13:20

Xamiol® - a New and Effective Treatment for Scalp Psoriasis

P. van de Kerkhof (Nijmegen, Netherlands)

SAT03.3

13:40

Practical Aspect and Experience exchange with Xamiol® treatment

A. Bewley (London, United Kingdom)

SAT03.4

14:00

Treatment of Facial and Inverse Psoriasis - How do you Treat?

M. Deleuran (Arhus, Denmark )

SAT03.5

14:20

Nail Psoriasis - a Challenge for us all

U. Mrowietz (Kiel, Germany)

SAT03.6

14.40

Closing remarks

U. Mrowietz (Kiel, Germany)

SAT04.1

13.15

Oxydative Stress and Skin Aging

M. Podda (Frankfurt, Germany)

SAT04.2

13.30

Glycation Process and Skin Aging

M. Böhm (Munster, Germany)

SAT04.3

13.45

DERM AOX a Well Balanced Active Ingredients Composition

A. Rougier (Asnières, France)

SAT04.4

14.00

DERM AOX a Breakthrough Solution to Skin Aging: Clinical Evidence

P. Humbert (Besançon, France)

SAT04.5

14.20

Conclusion to the Symposium

M. Podda (Frankfurt, Germany)

SAT05.1

13.15

Welcome and Introduction

P. Wolkenstein (Creteil, France)

SAT05.2

13.20

The Daily challenge of Psoriasis: the Point of View of the Patient

D. Sid-Mohand (Paris, France)

SAT05.3

13.45

Psoriasis: From Physiopathology to Therapeutic Approach

SAT05.4

14.10

The Therapeutic Advantages of BMV Plaster in Chronic Plaque Psoriasis
Results from a New European, Multicentric Study

M. Esposito (Rome, Italy)

SAT05.5

14.35

Discussion and Conclusion

SAT06.1

13.15

Welcome

A. Hauschild (Kiel, Germany)

SAT06.2

13.20

Improving PDT: Review and Outlook

C. Morton (Stirling, United Kingdom)

SAT06.3

13.40

Patch PDT: Simplicity that Works

R.M. Szeimies (Regensburg, Germany)

SAT06.4

14.00

New Simplicity - Excellent Efficacy

A. Hauschild (Kiel, Germany)

SAT06.5

14.20

Evolution in PDT - Longterm Results

E. Stockfleth (Berlin, Germany)

SAT06.6

14.40

Closing

A. Hauschild (Kiel, Germany)

SAT07.1.

13:15

Welcome and Introduction

D. Wallach (Paris, France)

SAT07.2.

13:20

Update on the Pathophysiology of Atopic Dermatitis

J.F Nicolas (Lyon, France)

SAT07.3

13:45

Immunological properties of Avena Rhealba Plantlets

T. Bieber (Bonn, Germany)

SAT07.4

14:10

SCORAD and PO-SCORAD Indexes in the Management of Atopic Dermatitis Patients

J.F. Stalder (Nantes, France)

SAT07.5

14:35

Discussion and Conclusion

SAT08.1

17.00

Welcome and Introduction

N. H. Shear (Toronto, Canada)

SAT08.2

17.10

Interactive Case-Based Panel Discussion

U. Mrowietz (Kiel, Germany)

A. Ogilvie (Erlangen, Germany)

M. Papoutsaki (Rome, Italy)

SAT08.3

18.10

Question-and-Answer Session

SAT09.1

17:00

Welcome and Introduction

T. Luger (Munster, Germany)

SAT09.2

17:05

Management of Psoriasis in Patients with Cardiovascular Disease

K. Papp (Toronto, Canada)

SAT09.3

17:25

Psoriasis Management and Tuberculosis Infection

M. Stahle (Stockhol, Sweden)

SAT09.4

17:45

Combining the Management of Psoriasis with Family Planning

K. Papp (Toronto, Canada)

SAT09.5

18:05

Management of Psoriasis in Children and Adolescents

M. Stahle (Stockhol, Sweden)

SAT09.6

18:25

Closing Remarks

T. Luger (Munster, Germany)

SAT10.1

17.00

Welcome & Introduction

F. Rippke (Hamburg, Germany)

SAT10.2

17.05

Botanicals for Medical Skin Care - Modern Actives with a Strong Heritage

B. Dräger ( Halle, Germany)

SAT10.3

17.25

Licochalcone A from Glycyrrhiza Inflata - an Anti-inflammatory Active with a Broad and Unique Action Profile

L. Kolbe (Hamburg, Germany)

SAT10.4

17.45

Licochalcone A - Clinical Efficacy in Inflammatory Skin Diseases and Sun Protection

G. Neufang (Hamburg, Germany)

SAT10.5

18.05

Closing Remarks

F. Rippke (Hamburg, Germany)

SAT11.1

17.05

What is Corrective Make Up?

C. Lebre Lemonnier (Chevilly Larue, France)

SAT11.2

17.25

Corrective Make Up and Quality of Life

A. Bouloc (Paris, France)

SAT11.3

17.45

Medical and Aesthetic Indications for Corrective Make-Up

C. Bayerl (Wiesbaden, Germany)

SAT11.4

18.05

How to Set Up a Corrective Make up Clinic?

Z. Dralos (High point, USA)

SAT12.1

13:00

Chairman's Introduction

C. Griffiths (Salford, United Kingdom)

SAT12.2

13:05

Efficacy: A Key Driver in the Successful Management of Psoriasis
R. Langley (Nova Scotia, Canada)

SAT12.3

13:30

Putting Biologic Safety in Perspective

K. Reich (Hamburg, Germany)

SAT12.4

13:55

Psoriasis and Persistent Life Effects 

SAT12.5

14:20

Panel Discussion

SAT13.1

13:00

Exploring Safety In The Long Term
C. Paul (Toulouse, France)

SAT13.2

13:10

Probing The Skin Barrier
M. Cork (Sheffield, United Kingdom)

SAT13.3

13:35

Looking at The Underlying Inflammation
T. Bieber (Bonn, Germany)

SAT13.4

14:00

Analysing The CONTROL Results
S. Reitamo (Helsinki, Finland)

SAT13.5

Your Questions

SAT14.1

13.00

Introduction
H. Gollnick (Magdeburg, Germany)

SAT14.2

13.05

How to Detect Poor Adherence in Clinical Practice
B. Dréno (Nantes, France)

SAT14.3

 13.20

New Tools to Optimize Results of Acne Treatment: An Interactive Learning Session
H. Gollnick (Magdeburg, Germany)

SAT14.4

13.45

Question & Answer

SAT14.5

13.55

Acne Scarring as a Challenge for Treatment
M. Podda (Darmstadt, Germany)

SAT14.6

14.10

What Recent Evidence Supports a Further Link Between Diet and Acne?
D. Thiboutot (Hershey, USA)

SAT14.7

14.25

Question and Answer

SAT15.1

 13.00

Welcome & Introduction
T. Luger (Muenster, Germany)

SAT15.2

13.05

Chronic Hand Eczema (CHE) – A Challenging Disease With a Significant Burden to Patients and Society
O. Chosidow (Paris, France)

SAT15.3

13.25

Alitretinoin - An Innovation for the Treatment of Severe CHE – Key Data from Clinical Trials
R. Graham-Brown (Leicester, United Kingdom)

SAT15.4

13.45

Alitretinoin in Clinical Practice – Making a Difference to Patients
T. Dirschka (Wuppertal, Germany)

SAT15.5

14.05

Hand Eczema Treatment Guidelines – An Overview
T. Luger (Muenster, Germany)

SAT15.6

14.20

Q & A, Summary & Close
T. Ruzicka (Munich, Germany)

SAT17.1

13:00

Physical, mechanical and ENERPEEL chemical exfoliation: a general overview
E. Berardesca (Rome, Italy)

SAT17.2

13:10

Evaluation of the effects of different ENERPEEL medical devices using in-vivo reflectance confocal microscopy:
M. Ardigò (Rome, Italy)

SAT17.3

13:25

Cytoceuticals TEBISKIN: biochemical mechanism of action
G. de Paoli Ambrosi (Salò, Italy)

SAT17.4

13:45

Detailed protocols to treat different skin pathologies which is the most indicated acid to perform chemioexfoliation?
M. Sokolowska Wojdylo (Gdansk, Poland)

SAT17.5

14:10

Skin rejuvenation: how to treat chrono and photo ageing comparing chemical, physical, and mechanical techniques.
S. Truedsson (Oslo, Norway)